Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study
Authors:
- 4 December 2024
- journal article
- research article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 185, 109504
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countriesBMC Neurology, 2022
- Predicting Parkinson's disease using gradient boosting decision tree models with electroencephalography signalsParkinsonism & Related Disorders, 2022
- Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsParkinsonism & Related Disorders, 2021
- Feature Selection and Classification Using CatBoost Method for Improving the Performance of Predicting Parkinson’s Disease2020
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideMovement Disorders Clinical Practice, 2020
- Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approachCurrent Medical Research and Opinion, 2018
- Using Smartphones and Machine Learning to Quantify Parkinson Disease SeverityJAMA Neurology, 2018
- Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness studyJournal of Neurology, 2015
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Validity and Efficacy of Screening Algorithms for Assessing Deep Brain Stimulation Candidacy in Parkinson's DiseaseMovement Disorders Clinical Practice, 2014